AMLX vs PG · rev $87.4M vs P/E 25, rev $84.28B
Amylyx Pharmaceuticals Inc (AMLX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
AMLX currently screens at market cap $561.6M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the AMLX and PG stock pages for the full models.
Not investment advice.